CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

Voglibose 50mg  | ≥98%

CSNpharm

Voglibose, an N-substituted derivative of valiolamine, can inhibit α-glucosidase and be used to treat hyperglycemia and its concomitant diseases.

More Information Supplier Page

Voglibose 100mg  | ≥98%

CSNpharm

Voglibose, an N-substituted derivative of valiolamine, can inhibit α-glucosidase and be used to treat hyperglycemia and its concomitant diseases.

More Information Supplier Page

Voglibose 10mg  | ≥98%

CSNpharm

Voglibose, an N-substituted derivative of valiolamine, can inhibit α-glucosidase and be used to treat hyperglycemia and its concomitant diseases.

More Information Supplier Page

Voleneol 5mg  | ≥98%

CSNpharm

Voleneol, a natural product isolated and purified from the herbs of Curcuma wenyujin, can attenuate the lipopolysaccharide (LPS)-induced inflammation in BV2 microglial cells. it also can dose-dependently suppress the protein expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), suggest thats DE may be a good candidate to regulate LPS-induced inflammatory response.

More Information Supplier Page

Voleneol 1mg  | ≥98%

CSNpharm

Voleneol, a natural product isolated and purified from the herbs of Curcuma wenyujin, can attenuate the lipopolysaccharide (LPS)-induced inflammation in BV2 microglial cells. it also can dose-dependently suppress the protein expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), suggest thats DE may be a good candidate to regulate LPS-induced inflammatory response.

More Information Supplier Page

Voriconazole 100mg  | ≥99%

CSNpharm

Voriconazole is a second-generation triazole antifungal used to treat serious fungal infections by inhibiting the synthesis of ergosterol, the major sterol of the fungal cell membrane.

More Information Supplier Page

Voriconazole 50mg  | ≥99%

CSNpharm

Voriconazole is a second-generation triazole antifungal used to treat serious fungal infections by inhibiting the synthesis of ergosterol, the major sterol of the fungal cell membrane.

More Information Supplier Page

Voriconazole 10mg  | ≥99%

CSNpharm

Voriconazole is a second-generation triazole antifungal used to treat serious fungal infections by inhibiting the synthesis of ergosterol, the major sterol of the fungal cell membrane.

More Information Supplier Page

VU 0238429 50mg  | ≥98%

CSNpharm

VU 0238429 is a selective positive allosteric modulator of M5 receptors with EC50 values of 1.16, >30 and >30 μM at M5, M1 and M3 receptors respectively.

More Information Supplier Page

VU 0238429 25mg  | ≥98%

CSNpharm

VU 0238429 is a selective positive allosteric modulator of M5 receptors with EC50 values of 1.16, >30 and >30 μM at M5, M1 and M3 receptors respectively.

More Information Supplier Page

VU 0238429 100mg  | ≥98%

CSNpharm

VU 0238429 is a selective positive allosteric modulator of M5 receptors with EC50 values of 1.16, >30 and >30 μM at M5, M1 and M3 receptors respectively.

More Information Supplier Page

VU 0240551 10mg  | ≥98%

CSNpharm

VU 0240551 is a small molecule inhibitor of the neuronal K-Cl cotransporter, KCC2 (IC50 = 560 nM for K+ uptake assay in KCC2-overexpressing cells).

More Information Supplier Page

VU 0240551 5mg  | ≥98%

CSNpharm

VU 0240551 is a small molecule inhibitor of the neuronal K-Cl cotransporter, KCC2 (IC50 = 560 nM for K+ uptake assay in KCC2-overexpressing cells).

More Information Supplier Page

VU 0240551 50mg  | ≥98%

CSNpharm

VU 0240551 is a small molecule inhibitor of the neuronal K-Cl cotransporter, KCC2 (IC50 = 560 nM for K+ uptake assay in KCC2-overexpressing cells).

More Information Supplier Page

VU 0240551 25mg  | ≥98%

CSNpharm

VU 0240551 is a small molecule inhibitor of the neuronal K-Cl cotransporter, KCC2 (IC50 = 560 nM for K+ uptake assay in KCC2-overexpressing cells).

More Information Supplier Page

VU 0240551 1mg  | ≥98%

CSNpharm

VU 0240551 is a small molecule inhibitor of the neuronal K-Cl cotransporter, KCC2 (IC50 = 560 nM for K+ uptake assay in KCC2-overexpressing cells).

More Information Supplier Page

VU 0361737 25mg  | ≥99%

CSNpharm

VU 0361737 is a brain-penetrant and selective positive allosteric modulator of mGlu4 receptors with EC50 values of 240 nM.

More Information Supplier Page

VU 0361737 5mg  | ≥99%

CSNpharm

VU 0361737 is a brain-penetrant and selective positive allosteric modulator of mGlu4 receptors with EC50 values of 240 nM.

More Information Supplier Page

VU 0361737 100mg  | ≥99%

CSNpharm

VU 0361737 is a brain-penetrant and selective positive allosteric modulator of mGlu4 receptors with EC50 values of 240 nM.

More Information Supplier Page

VU 0361737 10mg  | ≥99%

CSNpharm

VU 0361737 is a brain-penetrant and selective positive allosteric modulator of mGlu4 receptors with EC50 values of 240 nM.

More Information Supplier Page

VU 0361737 50mg  | ≥99%

CSNpharm

VU 0361737 is a brain-penetrant and selective positive allosteric modulator of mGlu4 receptors with EC50 values of 240 nM.

More Information Supplier Page

VU 0364770 5mg  | ≥99%

CSNpharm

VU 0364770 is a brain-penetrant and positive allosteric modulator of mGlu4 receptors with EC50 values of 290 nM. It also exhibits affinity for MAO-B and MAO-A with Ki values of 0.72 μM and 8.5 μM, respectively.

More Information Supplier Page

VU 0364770 100mg  | ≥99%

CSNpharm

VU 0364770 is a brain-penetrant and positive allosteric modulator of mGlu4 receptors with EC50 values of 290 nM. It also exhibits affinity for MAO-B and MAO-A with Ki values of 0.72 μM and 8.5 μM, respectively.

More Information Supplier Page

VU 0364770 25mg  | ≥99%

CSNpharm

VU 0364770 is a brain-penetrant and positive allosteric modulator of mGlu4 receptors with EC50 values of 290 nM. It also exhibits affinity for MAO-B and MAO-A with Ki values of 0.72 μM and 8.5 μM, respectively.

More Information Supplier Page

VU 0364770 10mg  | ≥99%

CSNpharm

VU 0364770 is a brain-penetrant and positive allosteric modulator of mGlu4 receptors with EC50 values of 290 nM. It also exhibits affinity for MAO-B and MAO-A with Ki values of 0.72 μM and 8.5 μM, respectively.

More Information Supplier Page

VU 0364770 50mg  | ≥99%

CSNpharm

VU 0364770 is a brain-penetrant and positive allosteric modulator of mGlu4 receptors with EC50 values of 290 nM. It also exhibits affinity for MAO-B and MAO-A with Ki values of 0.72 μM and 8.5 μM, respectively.

More Information Supplier Page

VU-0155069 5mg  | ≥98%

CSNpharm

VU-0155069 is a selective phospholipase D1 (PLD1) inhibitor with IC50 values of 46 and 933 nM for PLD1 and PLD2 respectively.

More Information Supplier Page

VU-0155069 1mg  | ≥98%

CSNpharm

VU-0155069 is a selective phospholipase D1 (PLD1) inhibitor with IC50 values of 46 and 933 nM for PLD1 and PLD2 respectively.

More Information Supplier Page

VU0119498 25mg  | ≥98%

CSNpharm

VU0119498 is a M1 muscarinic receptor agonist with EC50 of 3.1 μM, and pan mAChR M3, M5 positive allosteric modulator (PAM),and is a neuroprotective agent.

More Information Supplier Page

VU0119498 50mg  | ≥98%

CSNpharm

VU0119498 is a M1 muscarinic receptor agonist with EC50 of 3.1 μM, and pan mAChR M3, M5 positive allosteric modulator (PAM),and is a neuroprotective agent.

More Information Supplier Page